Difference between revisions of "About-cancer/treatment/drugs/thyroid"
Jump to navigation
Jump to search
(Created page with "== Drugs Approved for Thyroid Cancer == This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names an...") |
|||
Line 1: | Line 1: | ||
+ | <languages/> | ||
+ | <translate> | ||
== Drugs Approved for Thyroid Cancer == | == Drugs Approved for Thyroid Cancer == | ||
Line 30: | Line 32: | ||
Vandetanib | Vandetanib | ||
+ | </translate> |
Revision as of 18:38, 28 October 2019
Drugs Approved for Thyroid Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for thyroid cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in thyroid cancer that are not listed here.
Drugs Approved for Thyroid Cancer
Cabozantinib-S-Malate
Caprelsa (Vandetanib)
Cometriq (Cabozantinib-S-Malate)
Dabrafenib Mesylate
Doxorubicin Hydrochloride
Lenvatinib Mesylate
Lenvima (Lenvatinib Mesylate)
Mekinist (Trametinib)
Nexavar (Sorafenib Tosylate)
Sorafenib Tosylate
Tafinlar (Dabrafenib Mesylate)
Trametinib
Vandetanib